Funder
USAID
Overview
The Evidence to Action (E2A) Project is a global, $290 million, 10-year cooperative agreement funded by the United States Agency for International Development (USAID) to strengthen family planning and reproductive health service delivery. From 2011–2021, E2A addressed the reproductive healthcare needs of girls, women, and underserved communities around the world by increasing support, building evidence, and facilitating the scale-up of high-impact practices that can transform the health of families, communities, and nations.
Across 17 countries, E2A advanced evidence-based practices that have improved reproductive health and contributed to reductions in unintended pregnancies and gender disparities. As a result, today, more women and girls can make—and act on—informed decisions that ensure the healthiest outcomes for themselves and their families.
Pathfinder led E2A, in collaboration with ExpandNet, IntraHealth International, PATH, Management Sciences for Health, and African Population and Health Research Center.
To learn about E2A’s impact and results, take a look at:
- E2A’s Final Report
- E2A Resources Hub—a full catalog of useful resources, tools, peer-reviewed journal articles and more.
Project Activities
- Advanced quality services made with and for youth—specific to their country context, their needs and desires, available services, financial resources, and objectives for scalability and sustainability.
- Systematically scaled up community-based family planning; innovative peer education approaches for youth; integrated population, health, and environment activities; and task-shifting and task-sharing to expand method choice.
- Expanded access to a full range of contraceptive options with special attention to the promotion of client-centered, voluntary, and informed choice.
- Seized opportunities to broaden the impact of family planning by creating synergistic and mutually beneficial partnerships across sectors, closing evidence gaps, and engaging stakeholders who are often left behind.